DB
IRMD icon

Dmitry Balyasny’s iRadimed IRMD Stock Holding History

Dmitry Balyasny’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,498
Closed -$632K – 3194
2025
Q4 		$632K Buy
+6,498
New +$557K ﹤0.01% 2415

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dmitry Balyasny's IRMD Position: Q1 2026 in Review

Dmitry Balyasny sold out of iRadimed (IRMD) in Q1 2026, closing a stake of 6,498 shares — an estimated $632K sold.

Dmitry Balyasny first reported a position in IRMD in Q4 2025 and held it in 1 quarter. The position peaked at $632K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Dmitry Balyasny reported no remaining iRadimed position as of Q1 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 6,498 iRadimed shares in Q1 2026, an estimated $632K.
  • Dmitry Balyasny first reported a position in iRadimed in Q4 2025 and held it in 1 quarter.
  • Dmitry Balyasny's iRadimed position peaked at $632K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.